| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/18/2000 | US6090395 Skin antiseptics; alcohol and chlorhexidine digluconate, with thickener |
| 07/18/2000 | US6090389 Method and preparations for the treatment of fungus |
| 07/18/2000 | US6090368 Pharmaceutical compositions for intranasal spray administration of ketorolac tromethamine |
| 07/18/2000 | US6090139 Medical devices using electrosensitive gels |
| 07/18/2000 | CA2295790A1 Controlled release tramadol preparations having a storage-stable table release profile and process for the production thereof |
| 07/18/2000 | CA2295471A1 Opioid analgesics with controlled active substance release |
| 07/18/2000 | CA2295470A1 Process for the preparation of pellets with a content of up to 90 wt.% of a pharmaceutical active ingredient |
| 07/18/2000 | CA2295469A1 Analgesic with controlled active substance release |
| 07/18/2000 | CA2259730A1 Sustained release tablets containing bupropion hydrochloride |
| 07/18/2000 | CA2259727A1 A two-layer pharmaceutical tablet comprising an nsaid and misoprostol |
| 07/18/2000 | CA2202707C Non-aqueous oral-drench compositions containing avermectin compounds |
| 07/18/2000 | CA2148651C Halogenated antifungal and antibacterial compounds used for reducing hair loss |
| 07/18/2000 | CA2132933C Soft gelatin capsule manufacture |
| 07/18/2000 | CA2129051C Absorbable composite materials for use in the treatment of periodontal disease |
| 07/18/2000 | CA2087087C Molecules for iontophoretic delivery |
| 07/18/2000 | CA2044398C Programmed release oral solid pharmaceutical dosage form |
| 07/18/2000 | CA2027501C Process for preparation of an aqueous dispersion of lipid vesicles and composition containing the dispersion thereby obtained |
| 07/18/2000 | CA2014714C A method of preparing a freeze-dried formulation containing a drug |
| 07/18/2000 | CA2008183C Liquid pharmaceutical composition for piperidinoalkanol derivatives |
| 07/13/2000 | WO2000040962A1 Cyclodextrin polymers for use as drug carriers |
| 07/13/2000 | WO2000040699A2 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | WO2000040696A1 Preservation of sensitive biological materials at ambient temperatures by vitrification |
| 07/13/2000 | WO2000040592A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | WO2000040591A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | WO2000040269A2 Pharmaceutical compositions for treatment of diseased tissues |
| 07/13/2000 | WO2000040262A1 Novel agents and methods for treatment and diagnosis of ocular disorders |
| 07/13/2000 | WO2000040259A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | WO2000040255A1 Cream composition comprising dead sea mud |
| 07/13/2000 | WO2000040254A1 Pharmaceutical composition for oral administration having therapeutic activity on gastrointestinal disorders |
| 07/13/2000 | WO2000040250A1 Amelometasone lotion |
| 07/13/2000 | WO2000040248A1 Method and composition for treatment of female sexual dysfunction |
| 07/13/2000 | WO2000040236A1 Stabile and sterile emulsion which contains taxanes, and method for the production thereof |
| 07/13/2000 | WO2000040234A1 Topical anesthesia of the urinary bladder |
| 07/13/2000 | WO2000040233A1 Pharmaceutical composition containing metformin, acarbose or glimepiride and optionally poly-(dimethyl)-siloxane |
| 07/13/2000 | WO2000040232A2 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
| 07/13/2000 | WO2000040228A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 07/13/2000 | WO2000040224A1 Multiparticulate oral dosage forms |
| 07/13/2000 | WO2000040223A1 Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings |
| 07/13/2000 | WO2000040222A1 Method for producing solid dosage forms |
| 07/13/2000 | WO2000040221A1 Preparation of microparticles having a selected release profile |
| 07/13/2000 | WO2000040220A1 Method of preparing pharmaceutical active ingredient comprising water-insoluble drug and pharmaceutical composition for oral administration comprising the same |
| 07/13/2000 | WO2000040219A1 Dispersible concentrate for the delivery of cyclosporin |
| 07/13/2000 | WO2000040218A2 Osmotic delivery system having space efficient piston |
| 07/13/2000 | WO2000040217A1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/13/2000 | WO2000040205A2 Sustained release formulation with reduced moisture sensitivity |
| 07/13/2000 | WO2000040203A2 Polymeric delivery agents and delivery agent compounds |
| 07/13/2000 | WO2000040189A1 Medical pressure-sensitive adhesive tape |
| 07/13/2000 | WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | WO2000040086A1 Formulations for treating disease and methods of using same |
| 07/13/2000 | WO2000027363B1 Aerosols comprising nanoparticle drugs |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000021487A3 Formoterol polymorphs |
| 07/13/2000 | WO2000019976A3 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/13/2000 | WO2000010582A3 Probiotic, lactic acid-producing bacteria and uses thereof |
| 07/13/2000 | WO2000006534A9 Compounds and compositions for delivering active agents |
| 07/13/2000 | DE19900749A1 A topically applied film-forming composition contains antiandrogenic N-phenyl-azolidine compound, used for treating hirsutism, seborrhea, acne or especially androgenetic alopecia |
| 07/13/2000 | DE19900645A1 Transdermal therapeutic system, has drug release matrix on base foil subdivided into unit dose portions allowing selection of dose by patient |
| 07/13/2000 | DE19900457A1 Verfahren zur Herstellung von festen Dosierungsformen A process for the preparation of solid dosage forms |
| 07/13/2000 | CA2778317A1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 07/13/2000 | CA2360032A1 Preservation of sensitive biological materials at ambient temperatures by vitrification |
| 07/13/2000 | CA2358570A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | CA2358495A1 Prolonged release microsphere encapsulating luteinizing hormone-releasing hormone analogues and method for preparing the same |
| 07/13/2000 | CA2358463A1 Polymeric delivery agents and delivery agent compounds |
| 07/13/2000 | CA2358212A1 Formulations for treating disease and methods of using same |
| 07/13/2000 | CA2357986A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | CA2356368A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | CA2355967A1 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | CA2355829A1 Multiparticulate oral dosage forms |
| 07/13/2000 | CA2353592A1 Method and composition for treatment of female sexual dysfunction |
| 07/13/2000 | CA2322293A1 Hydroxypropylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings |
| 07/12/2000 | EP1018363A1 Nanoemulsion based on sequenced copolymers of ethylene oxyde and propylene oxyde and uses thereof in the fields of cosmetics, dermatology and/or ophthalmology |
| 07/12/2000 | EP1018345A1 Water soluble dry compositions |
| 07/12/2000 | EP1018340A1 Inclusion aminoacid salts compounds of benzimidazole derivatives with cyclodextrins, their preparation and pharmaceutical formulations containing them |
| 07/12/2000 | EP1018337A2 Formulations containing chlorhexidine, novel chlorhexidine salts,solutions containing the aforesaid chlorhexidine salts and their use |
| 07/12/2000 | EP1018335A1 Process for formulating granular matrices by precipitation of polmymers in an acidic medium |
| 07/12/2000 | EP1017790A1 Methods and compositions for binding hematopoietic stem cells |
| 07/12/2000 | EP1017741A1 Non-expanding agent method for producing flat-shaped polymer foams |
| 07/12/2000 | EP1017696A1 Acidic addition salts of morphine alkaloids and the application thereof |
| 07/12/2000 | EP1017673A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents |
| 07/12/2000 | EP1017440A1 Method of delivering halotherapy |
| 07/12/2000 | EP1017413A1 LIQUID INTERFERON-$g(b) FORMULATIONS |
| 07/12/2000 | EP1017411A1 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS |
| 07/12/2000 | EP1017404A1 Pharmaceutical composition for the treatment of inflammatory bowel disease |
| 07/12/2000 | EP1017392A1 Medicament formulation with a controlled release of an active agent |
| 07/12/2000 | EP1017391A2 Sustained release tablet formulation to treat parkinson disease |
| 07/12/2000 | EP1017390A2 Combinations of hmg-coa inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night |
| 07/12/2000 | EP1017386A1 GRANULAR PREPARATIONS OF 5-(2-ETHYL- 2$i(H)-TETRAZOL- 5-YL)-1-METHYL-1, 2,3,6-TETRAHYDROPYRIDINE |
| 07/12/2000 | EP1017381A1 Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome |
| 07/12/2000 | EP1017380A1 Topical non-steroidal anti-inflammatory drug composition |
| 07/12/2000 | EP1017372A1 Controlled release solid dosage forms of lithium carbonate |
| 07/12/2000 | EP1017371A4 Controlled release of drugs delivered by sublingual or buccal administration |
| 07/12/2000 | EP1017371A1 Controlled release of drugs delivered by sublingual or buccal administration |
| 07/12/2000 | EP1017370A1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs) |
| 07/12/2000 | EP1017369A1 Local oral herbal slow release tablets |
| 07/12/2000 | EP1017368A2 Self-binding shearform compositions |
| 07/12/2000 | EP1017367A1 Methods for fabricating polymer-based controlled release preparions |
| 07/12/2000 | EP1017366A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances |
| 07/12/2000 | EP1017365A1 Liposome-entrapped polynucleotide composition and method |
| 07/12/2000 | EP1017364A1 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 07/12/2000 | EP1017363A1 Taste masking for unpalatable formulations |